Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$0.2 - $0.35 $70,000 - $122,499
350,000 Added 437.5%
430,000 $90,000
Q1 2022

May 02, 2022

BUY
$0.28 - $0.61 $22,400 - $48,800
80,000 New
80,000 $23,000

About ACELRX PHARMACEUTICALS INC


  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Texas Capital Bank Wealth Management Services Inc Portfolio

Follow Texas Capital Bank Wealth Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Capital Bank Wealth Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Texas Capital Bank Wealth Management Services Inc with notifications on news.